| John-paul Cloutier, NP | |
|
607 Washington Hwy, Morrisville, VT 05661-8652 | |
| (802) 888-8320 | |
| Not Available |
| Full Name | John-paul Cloutier |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner |
| Experience | 5 Years |
| Location | 607 Washington Hwy, Morrisville, Vermont |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205492196 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LP0808X | Nurse Practitioner - Psychiatric/mental Health | 101.0134317 (Vermont) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Savida Health, Pc | 4082809967 | 77 |
| Savida Health, Pc | 4082809967 | 77 |
News Archive
Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that the National Institute of Allergy and Infectious Diseases has exercised its option to advance preclinical development of OrbeShield (oral beclomethasone 17,21-dipropionate or oral BDP).
The Wall Street Journal: "After years of frustration, workers sickened in the recovery and cleanup efforts after the Sept. 11 terrorist attacks are on the verge of getting paid for their illnesses. Yet the proposed legal settlement of up to $712 million also would pay money to thousands of people who aren't sick at all. That's just one of the concerns that could scuttle the proposed deal, which requires approval of 95% of those suing for compensation."
RainDance Technologies, Inc., a leading provider of innovative microdroplet-based solutions for human health and disease research, and Applied Biosystems, part of Life Technologies Corporation, announced today they have entered into a strategic agreement to co-market the first solution that combines microdroplet PCR-based sequence enrichment with next-generation sequencing.
The next stage in the landmark 2006 health reform law is to scale back the growth in health care costs.
› Verified 7 days ago
| Entity Name | Springfield Hospital Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780657783 PECOS PAC ID: 6507760337 Enrollment ID: O20040130000327 |
News Archive
Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that the National Institute of Allergy and Infectious Diseases has exercised its option to advance preclinical development of OrbeShield (oral beclomethasone 17,21-dipropionate or oral BDP).
The Wall Street Journal: "After years of frustration, workers sickened in the recovery and cleanup efforts after the Sept. 11 terrorist attacks are on the verge of getting paid for their illnesses. Yet the proposed legal settlement of up to $712 million also would pay money to thousands of people who aren't sick at all. That's just one of the concerns that could scuttle the proposed deal, which requires approval of 95% of those suing for compensation."
RainDance Technologies, Inc., a leading provider of innovative microdroplet-based solutions for human health and disease research, and Applied Biosystems, part of Life Technologies Corporation, announced today they have entered into a strategic agreement to co-market the first solution that combines microdroplet PCR-based sequence enrichment with next-generation sequencing.
The next stage in the landmark 2006 health reform law is to scale back the growth in health care costs.
› Verified 7 days ago
| Entity Name | Northeast Kingdom Human Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043372709 PECOS PAC ID: 0941276703 Enrollment ID: O20041012001355 |
News Archive
Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that the National Institute of Allergy and Infectious Diseases has exercised its option to advance preclinical development of OrbeShield (oral beclomethasone 17,21-dipropionate or oral BDP).
The Wall Street Journal: "After years of frustration, workers sickened in the recovery and cleanup efforts after the Sept. 11 terrorist attacks are on the verge of getting paid for their illnesses. Yet the proposed legal settlement of up to $712 million also would pay money to thousands of people who aren't sick at all. That's just one of the concerns that could scuttle the proposed deal, which requires approval of 95% of those suing for compensation."
RainDance Technologies, Inc., a leading provider of innovative microdroplet-based solutions for human health and disease research, and Applied Biosystems, part of Life Technologies Corporation, announced today they have entered into a strategic agreement to co-market the first solution that combines microdroplet PCR-based sequence enrichment with next-generation sequencing.
The next stage in the landmark 2006 health reform law is to scale back the growth in health care costs.
› Verified 7 days ago
| Entity Name | Brattleboro Retreat |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730185232 PECOS PAC ID: 7012828908 Enrollment ID: O20041123000627 |
News Archive
Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that the National Institute of Allergy and Infectious Diseases has exercised its option to advance preclinical development of OrbeShield (oral beclomethasone 17,21-dipropionate or oral BDP).
The Wall Street Journal: "After years of frustration, workers sickened in the recovery and cleanup efforts after the Sept. 11 terrorist attacks are on the verge of getting paid for their illnesses. Yet the proposed legal settlement of up to $712 million also would pay money to thousands of people who aren't sick at all. That's just one of the concerns that could scuttle the proposed deal, which requires approval of 95% of those suing for compensation."
RainDance Technologies, Inc., a leading provider of innovative microdroplet-based solutions for human health and disease research, and Applied Biosystems, part of Life Technologies Corporation, announced today they have entered into a strategic agreement to co-market the first solution that combines microdroplet PCR-based sequence enrichment with next-generation sequencing.
The next stage in the landmark 2006 health reform law is to scale back the growth in health care costs.
› Verified 7 days ago
| Entity Name | Savida Health, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598225021 PECOS PAC ID: 4082809967 Enrollment ID: O20180807001812 |
News Archive
Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that the National Institute of Allergy and Infectious Diseases has exercised its option to advance preclinical development of OrbeShield (oral beclomethasone 17,21-dipropionate or oral BDP).
The Wall Street Journal: "After years of frustration, workers sickened in the recovery and cleanup efforts after the Sept. 11 terrorist attacks are on the verge of getting paid for their illnesses. Yet the proposed legal settlement of up to $712 million also would pay money to thousands of people who aren't sick at all. That's just one of the concerns that could scuttle the proposed deal, which requires approval of 95% of those suing for compensation."
RainDance Technologies, Inc., a leading provider of innovative microdroplet-based solutions for human health and disease research, and Applied Biosystems, part of Life Technologies Corporation, announced today they have entered into a strategic agreement to co-market the first solution that combines microdroplet PCR-based sequence enrichment with next-generation sequencing.
The next stage in the landmark 2006 health reform law is to scale back the growth in health care costs.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John-paul Cloutier, NP 1 Anna Marsh Ln, Brattleboro, VT 05302 Ph: (802) 309-2044 | John-paul Cloutier, NP 607 Washington Hwy, Morrisville, VT 05661-8652 Ph: (802) 888-8320 |
News Archive
Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that the National Institute of Allergy and Infectious Diseases has exercised its option to advance preclinical development of OrbeShield (oral beclomethasone 17,21-dipropionate or oral BDP).
The Wall Street Journal: "After years of frustration, workers sickened in the recovery and cleanup efforts after the Sept. 11 terrorist attacks are on the verge of getting paid for their illnesses. Yet the proposed legal settlement of up to $712 million also would pay money to thousands of people who aren't sick at all. That's just one of the concerns that could scuttle the proposed deal, which requires approval of 95% of those suing for compensation."
RainDance Technologies, Inc., a leading provider of innovative microdroplet-based solutions for human health and disease research, and Applied Biosystems, part of Life Technologies Corporation, announced today they have entered into a strategic agreement to co-market the first solution that combines microdroplet PCR-based sequence enrichment with next-generation sequencing.
The next stage in the landmark 2006 health reform law is to scale back the growth in health care costs.
› Verified 7 days ago
Dr. Molly Heller, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 109 Professional Dr, Morrisville, VT 05661 Phone: 801-851-0999 | |
Alexander C. Johnston, PMHNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 65 Northgate Plaza, Suite 11, Morrisville, VT 05661 Phone: 802-888-8320 Fax: 802-888-8136 | |
Steacy Lynne Suddaby, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 609 Washington Hwy, Morrisville, VT 05661 Phone: 802-888-5639 Fax: 802-888-6040 | |
Elizabeth Ashley Douglas, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 609 Washington Hwy, Morrisville, VT 05661 Phone: 802-888-5639 | |
Elizabeth Hanna Steiner, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 528 Washington Hwy, Morrisville, VT 05661 Phone: 802-888-8372 Fax: 802-888-8131 | |
Susan Allen Hooper, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 528 Washington Highway, Acu, Morrisville, VT 05661 Phone: 802-888-8372 Fax: 802-888-8131 |